A Phase 1 Study to Evaluate the Drug-Drug Interaction Potential Between ALG-055009 and Statin Therapy(Ies)

Conditions: Healthy Volunteers Interventions: Drug: Atorvastatin; Drug: ALG-055009; Drug: Rosuvastatin Sponsors: Aligos Therapeutics Active, not recruiting

https://clinicaltrials.gov/study/NCT06191991

Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials